Search - tctmd.com

Displaying 1 - 20 of 134

Sort: Relevancy | Date

News Daily News

Risk Calculators Miss Many Patients Who Present With First MI

Michael O'Riordan

November 21, 2025

News Daily News

ACC: It’s Time for Clinicians to Address Inflammation in CVD

Caitlin E. Cox

October 03, 2025

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

News Daily News

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Caitlin E. Cox

May 06, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Daily News

Early Invasive Treatment May Help Highest-Risk Women With NSTE ACS

Yael L. Maxwell

March 10, 2025

News Daily News

ACC/AHA Release New Comprehensive ACS Guidelines

Todd Neale

February 27, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Daily News

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Todd Neale

December 20, 2024

News Daily News

EXCEL Data Highlight Bleeding Patterns After CABG, PCI for LM Disease

Yael L. Maxwell

December 05, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Daily News

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Michael O'Riordan

March 26, 2024

News Daily News

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Michael O'Riordan

March 14, 2024

News Daily News

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Michael O'Riordan

February 29, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

Advertisement

Risk Calculators Miss Many Patients Who Present With First MI

ACC: It’s Time for Clinicians to Address Inflammation in CVD

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Early Invasive Treatment May Help Highest-Risk Women With NSTE ACS

ACC/AHA Release New Comprehensive ACS Guidelines

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

BMJ Investigation Revives Questions About PLATO, Ticagrelor

EXCEL Data Highlight Bleeding Patterns After CABG, PCI for LM Disease

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Top Coronary Artery Disease News of 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content